Filippo Cademartiri on Why Vascular Health Is Cognitive Health
Filippo Cademartiri, Consultant Advanced Cardiovascular Imaging at UPMC Salvator Mundi International Hospital, shared on LinkedIn:
”’When the Heart and Brain Fail Together: Why Vascular Health Is Cognitive Health’
Cognitive impairment and cardiovascular disease are deeply connected in both biology and care delivery.
New evidence highlights that cognitive decline isn’t just an outcome of aging — it affects how patients receive and respond to heart care, and conversely, vascular health shapes cognitive trajectories.
People with cardiovascular disease (CVD) are at higher risk for cognitive impairment due to shared mechanisms like hypertension, cerebral hypoperfusion, inflammation, atrial arrhythmias, and microvascular injury.
Importantly, cognitive impairment reduces engagement with care: lower treatment adherence, delayed help-seeking, and under-prescription of guideline-directed therapies are all more common.
This creates a vicious cycle where heart disease worsens cognition and impaired cognition undermines cardiovascular care.
Therapeutically, progress in vascular cognitive impairment and dementia (VCID) has been modest compared to Alzheimer’s, but meaningful strategies exist.
Symptomatic cognitive enhancers (e.g., donepezil, memantine) may offer modest benefits, especially in mixed pathology.
Behavioral and environmental interventions remain first-line for neuropsychiatric symptoms.
The greatest impact comes from vascular risk management: aggressive control of blood pressure, diabetes, atrial fibrillation, smoking cessation, and promotion of physical activity not only protects the heart but also slows cognitive decline.
Take-home:
Screen for cognitive impairment in all cardiac patients
Treat the whole patient: cardiovascular + cognitive risk
Focus on aggressive vascular prevention as dementia prevention
Tailor care plans to support adherence and decision-making
Better cardiovascular health equals better brain health.”
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids